NASDAQ
No price data available for this timeframe.
Alto Neuroscience, Inc. (ANRO) has a free cash flow growth of -140.07% as of Friday, May 29, 2026. This represents a 9089.30% decrease compared to its 12-month average of 1.56%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.